Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Overview of Cell Viability and Cytotoxicity

What is Immunochemotherapy?

Cancer Pain Management

Cancer Screening Considerations: Balancing the Benefits and Risks

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Investigating the Molecular Mechanisms of Cancer

Cancer Glossary

What Role do Biobanks Play in Cancer Research?

Cancer Classification

What is Cancer?

What is Merkel Cell Carcinoma?

See more featured articles »

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

The Biochemistry of Breast Cancer Screening

Exploiting Enzymes in Cancer Diagnosis and Therapy

Caring for a Loved One with Cancer

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Transforming Cancer Care through Genomic Testing

CDK9 and Cancer

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

The Effects of Cancer on Family Life

Insight into Cancer Vaccines

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Using Biomarkers to Detect Cancer

Cancer History

Effects of Social and Economic Deprivation on Cancer Mortality

Extracellular Vesicles as Floating Cancer Biomarkers

Why are Cancer Cell Lines Useful?

Cancer Pain

Secondary Brain Cancer

Metastatic Migration in Cancer may be Influenced by Metabolism

Cutaneous Manifestations of Internal Malignancy

Targeted Cancer Therapies

What is Tumorigenesis?

Cancer Research

Cancer Prevention: Lowering your Risk

Cancer Epidemiology

Microfluidic cancer treatment screen combined with flow cytometry

What is Cancer of Unknown Primary?

Assay for Monitoring and Treating Malignant Brain Tumors

Insights into Oncofertility

Living with Cancer Pain

The Cancer Cell Surface Proteome as a Therapeutic Target

Pediatric Cancer

TARDIS: The Improved Method of Detecting Breast Cancer

What is the Tumor Microenvironment?

What Causes Cancer?

Myc Mutations and Cancer

British Pioneers in Cancer Biology

Cancer Prognosis

Is Cancer a Metabolic Disorder?

Secondary Lung Cancer

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cancer Symptoms

Hot vs Cold: the differences between tumor types

Cancer Diagnosis

Cancer Pathophysiology

Cancer Management

Hypoxia Markers and Their Importance

Acidosis and Tumor Progression

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Latest Cancer News and Research

Beer and liquor show more oral bacteria links than wine in a large US study

Researchers analyzed beverage intake and oral microbiome data from 5,598 adults across three US cohorts and found that alcohol consumption showed the strongest associations with oral bacterial diversity and composition among the beverages examined. Higher alcohol intake was associated with greater bacterial richness and differences in genera linked to oral health, but the cross-sectional preprint could not establish whether alcohol caused these differences or influenced disease risk.

26 Oct 2026

The vaginal microbiome may relate to more than reproductive health

Researchers analyzed vaginal microbiota, metabolites, and psychological questionnaire scores in 105 young Italian women and found associations between microbial community types and reward responsiveness, motivational drive, and behavioral inhibition. Exploratory models identified statistical links involving vaginal GABA and valine, but the cross-sectional study could not establish whether microbiome changes influence psychological functioning or the reverse.

26 Oct 2026

New drug effectively decreases recurrence of and death from endometrial cancer

A new drug is effective at decreasing recurrence of and death from endometrial cancer, a landmark international study shows.

26 Oct 2026

UCL scientists design symbolic AI digital twins to treat cancer

In a new paper published in Cell Reports Medicine, the UCL team outline how they, in collaboration with a University of Cambridge team, developed a new type of treatment-predicting computer program that uses an individual's detailed genetic fingerprint to explore which treatments, if any, may kill their cancer – especially when standard treatments have failed.

26 Oct 2026

Proteins linked to Alzheimer's found to assist sperm cells

Unexpectedly, a kind of protein that is usually linked with diseases in the brain may play a vital role in semen, helping shepherd genetic material into sperm cells, scientists at Columbia's Zuckerman Institute report today in the research journal Molecular Cell.

26 Oct 2026

Implantable drug-delivery device could help prevent recurrence of glioblastoma

Patients with glioblastoma, an aggressive type of brain tumor, usually undergo surgery to remove the tumor. However, it's difficult for surgeons to remove all of the cancer cells, and the tumor often recurs.

26 Oct 2026

Friends play a direct role in encouraging regular cancer screening

Friends may play a direct role in whether people keep up with cancer screening regularly, while family influence appears to operate more through knowledge and attitudes towards screening, according to new research by Singapore Management University's (SMU) Center for Research on Successful Ageing (ROSA).

26 Oct 2026

Medical societies release landmark framework redefining women's heart health

Today, the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine released a landmark publication that redefines heart health in girls and women.

26 Oct 2026

Smart probe makes aggressive breast cancer cells glow during surgery

Surgical removal of a tumor remains the primary defense against most solid cancers. However, for surgeons in the operating room, differentiating between the outer edges of a tumor and healthy tissue is a challenge.

26 Oct 2026

New report urges unified lifecycle approach to women's heart health

A new approach to women's heart health may offer them a lifetime of opportunities. A trio of scientific papers, published today in the journal Circulation, spells out how fluctuating hormones, mental health and well-being, the heart and the brain are linked and how those connections need to be a routine part of care from a young age.

26 Oct 2026

Black patients and people with learning disability face longer breast cancer care delays

Black patients and people with a learning disability face longer waiting times at key stages of breast cancer care, according to a nationwide study led by the University of Surrey.

26 Oct 2026

Study reveals a broad shift away from overtreatment of low-risk prostate cancer

An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer.

26 Oct 2026

Clues to prostate cancer risk in blood samples taken 15 years earlier

Recent study links blood proteins to aggressive prostate cancer, identifying potential biomarkers for early risk prediction and insights into immune activity.

26 Oct 2026

New archiving technique reveals past gene activity in cells

Information on what a cell did a few hours or days ago is generally unavailable to researchers, who can only measure the cell's current status.

26 Oct 2026

Taking a GLP-1 drug? Here's what the safety evidence really shows

A review on GLP-1 receptor agonists highlights risks like pancreatitis and thyroid cancer, emphasizing individual patient risk over general safety concerns.

26 Oct 2026

Next generation KRAS inhibitor divarasib significantly extends lung cancer survival

Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly longer and saw improved disease control when treated with the next-generation KRAS targeted therapy divarasib, according to researchers from The University of Texas MD Anderson Cancer Center.

26 Oct 2026

Phase 3 EMT2 trial demonstrates survival benefit for high-dose EPA

Patients assigned to receive high-dose eicosapentaenoic acid (EPA), an omega-3 fatty acid, before and after surgery for colorectal cancer liver metastases had longer overall survival than those assigned to receive placebo, according to results of the phase 3 EMT2 trial presented at the ESMO Congress 2026.

26 Oct 2026

Beer, wine or spirits: A large study finds different mortality patterns for each

Researchers analyzed data from 340,924 UK Biobank participants and found that high total alcohol consumption was associated with greater all-cause, cardiovascular, and cancer mortality, while moderate consumption was linked to increased cancer mortality. Beer/cider and spirits showed associations with higher mortality across several outcomes, whereas low-to-moderate wine consumption was linked to lower mortality for certain outcomes, though the observational study cannot establish causation.

25 Oct 2026

Personalized mRNA cancer vaccine cuts melanoma recurrence risk when added to immunotherapy

Adding a personalized mRNA-based cancer vaccine to immunotherapy after surgery for high-risk melanoma reduced the risk of recurrence or death by 42%, according to results from the phase 3 INTerpath-001 trial presented at the ESMO Congress 2026.

24 Oct 2026

Abiraterone triplet therapy improves long-term survival in metastatic prostate cancer

Adding abiraterone to standard treatment provides a lasting survival benefit for men whose prostate cancer has already spread at diagnosis, reinforcing the value of early treatment intensification.

24 Oct 2026